Cannabis and Psychedelics

October 31, 2024

Buy ($175)

Companies covered: COMPASS Pathways PLC (NASDAQ:CMPS), Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), GH Research PLC (NASDAQ:GHRS), Cybin Inc. (NYSEAMERICAN:CYBN), ATAI Life Sciences NV (NASDAQ:ATAI), BetterLife Pharma Inc. (OTCMKTS:BETRF), Cansortium Inc. (OTCMKTS:CNTMF), Greenlane Holdings Inc. (NASDAQ:GNLN), Planet 13 Holdings Inc. (OTCMKTS:PLNH)